Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients

[1] Gutiérrez OM(2008)Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 584-592

[2] Mannstadt M(2009)Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease Circulation 119 2545-2552

[3] Isakova T(2009)Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community Atherosclerosis. 205 385-390

[4] Gutiérrez OM(2009)Relationship between circulating FGF23 and total body atherosclerosis in the community Nephrol Dial Transplant 24 3125-3131

[5] Januzzi JL(2011)Lanthanum carbonate reduces FGF 23 in chronic kidney disease stage 3 patients Nephrol Dial Transplant 26 2567-2571

[6] Isakova T(2013)Effects of diet phosphate restriction and phosphate binders on FGF23 levels in CKD Clin J Am Soc Nephrol. 8 1009-1018

[7] Mirza MA(2012)Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial Am J Kidney Dis 59 177-185

[8] Larsson A(2010)Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol. 5 286-291

[9] Lind L(2013)The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients Clin Nephrol 80 17-22

[10] Mirza MA(2005)Sevelamer hydrochloride and calcium bi-carbonate reduce serum fibroblast growth factor 23 levels in dialysis patients Ther Apher Dial. 9 336-339

[1] Gutiérrez OM(2008)Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 584-592

[2] Mannstadt M(2009)Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease Circulation 119 2545-2552

[3] Isakova T(2009)Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community Atherosclerosis. 205 385-390

[4] Gutiérrez OM(2009)Relationship between circulating FGF23 and total body atherosclerosis in the community Nephrol Dial Transplant 24 3125-3131

[5] Januzzi JL(2011)Lanthanum carbonate reduces FGF 23 in chronic kidney disease stage 3 patients Nephrol Dial Transplant 26 2567-2571

[6] Isakova T(2013)Effects of diet phosphate restriction and phosphate binders on FGF23 levels in CKD Clin J Am Soc Nephrol. 8 1009-1018

[7] Mirza MA(2012)Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial Am J Kidney Dis 59 177-185

[8] Larsson A(2010)Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol. 5 286-291

[9] Lind L(2013)The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients Clin Nephrol 80 17-22

[10] Mirza MA(2005)Sevelamer hydrochloride and calcium bi-carbonate reduce serum fibroblast growth factor 23 levels in dialysis patients Ther Apher Dial. 9 336-339